Catalyst
Slingshot members are tracking this event:
Phase 3 data of Isunakinra (EBI-005) for Moderate to severe allergic conjunctivitis due 1Q 2016
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 15, 2016
Occurred Source:
http://ir.elevenbio.com/releasedetail.cfm?ReleaseID=950518
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ebi-005, Isunakinra, Allergic Conjunctivitis, Ocular Itching, Ocular Tearing
